Drug-Induced Endocrine and Metabolic Disorders
Authors: C.W., Ronald1; Kong, Alice P.S.; Chan, Norman2; Tong, Peter C.Y.1; Chan, Juliana C.N.1
Source: Drug Safety, Volume 30, Number 3, 2007 , pp. 215-245(31)
Publisher: Adis International
Abstract:
Complex interactions exist amongst the various components of the neuroendocrine system in order to maintain homeostasis, energy balance and reproductive function. These components include the hypothalamus-pituitary- adrenal and -gonadal axes, the renin-angiotensin-aldosterone system, the sympathetic nervous system and the pancreatic islets. These hormones, peptides and neurotransmitters act in concert to regulate the functions of many organs, notably the liver, muscles, kidneys, thyroid, bone, adrenal glands, adipocytes, vasculature, intestinal tract and gonads, through many intermediary pathways. Endocrine and metabolic disorders can arise from imbalance amongst numerous hormonal factors. These disturbances may be due to endogenous processes, such as increased secretion of hormones from a tumour, as well as exogenous drug administration. Drugs can cause endocrine abnormalities via different mechanisms, including direct alteration of hormone production, changes in the regulation of the hormonal axis, effects on hormonal transport, binding, and signalling, as well as similar changes to counter-regulatory hormone systems. Furthermore, drugs can affect the evaluation of endocrine parameters by causing interference with diagnostic tests. Common drug-induced endocrine and metabolic disorders include disorders of carbohydrate metabolism, electrolyte and calcium abnormalities, as well as drug-induced thyroid and gonadal disorders. An understanding of the proposed mechanisms of these drug effects and their evaluation and differential diagnosis may allow for more critical interpretation of the clinical observations associated with such disorders, better prediction of drug-induced adverse effects and better choices of and rationales for treatment.Keywords: ACE inhibitors; Alternative medicine; Amiodarone; Angiotensin II receptor antagonists; Antiepileptic drugs; Antihypertensives; Antimalarials; Antipsychotics; Antiretrovirals; Beta adrenoceptor antagonists; Bisphosphonates; Carbohydrate metabolism; Complementary and alternative medicine; Corticosteroids; Diabetes mellitus; Electrolyte imbalance; Endocrine disorders; Endocrine disorders; Environmental pollution; Gonadal disorders; Gynaecomastia; Herbal medicines; HIV protease inhibitors; Hypercalcaemia; Hyperglycaemia; Hyperkalaemia; Hypernatraemia; Hyperprolactinaemia; Hyperthyroidism; Hypocalcaemia; Hypoglycaemia; Hypokalaemia; Hyponatraemia; Hypothyroidism; Insulins; Interferon alpha; Levothyroxine sodium; Lipid metabolism disorders; Lithium; Metabolic disorders; Metabolic disorders; Metabolic syndrome; Obesity; Pentamidine; Peroxidase inhibitors; Renin inhibitors; Sexual function disorders; Sulfonylureas; Thyroid disorders
Document Type: Review article
Affiliations: 1: 1 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China 2: 3 Qualigenics Diabetes Centre, Hong Kong, China
Publication date: 2007-01-01
- In this: publication
- By this: publisher
- In this Subject: Ecology , Pharmacology , Toxicology
- By this author: C.W., Ronald ; Kong, Alice P.S. ; Chan, Norman ; Tong, Peter C.Y. ; Chan, Juliana C.N.

Shopping cart
Receive new issue alert
Get Permissions